有业内人士表示,虽然新医改规定将建立基本药物制度,但估计仅有几百种药品能最终入围基本药物目录,而市场流通的药品有上万种,药品流通领域体制并未被撼动。这就向基本药物制度提出了第一个挑战:如果纳入基本药物保障体系的,仅仅是“小概率”药品,就可能沦落为徒具观赏性的样本。正如民众对现行社保报销制度的一大抱怨——能够报销的药品太少,看病时需要的药不能报销,没有多大需求的药品反而享受报销待遇。这恰恰说明,如果不形成合理负担范围内 Insiders said that although the new medical reform will establish a basic drug system, it is estimated that only a few hundred kinds of drugs will eventually be included in the list of essential medicines. There are over 10,000 kinds of drugs in the market and the system of drug circulation has not been shaken. This poses the first challenge to the essential medicine system: if it is only “small” drugs that are included in the basic medicine guarantee system, it may be reduced to an ornamental sample. Just as the public complains about the current system of reimbursement of social security - there are too few drugs that can be reimbursed, medicines that are needed for medical treatment can not be reimbursed, and drugs that do not have much needed can instead enjoy reimbursement. This just shows that if you do not form a reasonable burden